CLOSED: Overcoming oncogenic androgen receptor signalling to transform the care of lethal prostate cancer

Primary supervisor: Dr Adam Sharp Primary site: Sutton Funded by Medical Research Council - Doctoral Training Partnership (MRC DTP)

CLOSED: Enabling Oral Delivery of VHL-based PROTACs Through Formulation and Prodrug Design

Primary supervisor: Professor Swen Hoelder Primary site: Sutton Funded by MRC iCASE CRODA Pharma

CLOSED: Folate-Degrader Conjugates (FDCs) for Tumour-specific Targeting

Primary supervisor: Professor Zoran Rankovic Primary site: Sutton Funded by MRC iCASE award (AstraZeneca)

CLOSED: Enhancer-Gene Networks as Therapeutic Targets in Multiple Myeloma

Primary supervisor: Professor Martin Kaiser Primary site: Sutton Funded by ICR

CLOSED: Combining AI and physics-based simulations for fragment-based cancer drug discovery

Primary supervisor: Dr Gary Newton Primary site: Sutton Funded by Medical Research Council - Doctoral Training Partnership (MRC DTP)

CLOSED: Elucidation of the molecular basis for the chaperoning of DEAH-box RNA helicases by the oncoprotein and cochaperone NudCD1

Primary supervisor: Dr Rob Van Montfort Primary site: Chelsea & Sutton Funded by ICR

CLOSED: Redox control of DNA replication: how mitochondrial ROS tune replisome function to preserve genome stability

Primary supervisor: Dr Jörg Mansfeld Primary site: Chelsea Funded by Medical Research Council - Doctoral Training Partnership (MRC DTP)

CLOSED: The Role of Early Plasma Cell Infiltration in Breast Cancer Immune Responses

Primary supervisor: Dr Esther Arwert Primary site: Chelsea Funded by ICR

Closed: Late-effects of paediatric cancer treatment

Primary supervisor: Professor Amy Berrington Primary site: Sutton Funded by NIHR

Closed: Computational analysis of spatial dynamics in breast cancer

Primary supervisor: Dr Esther Arwert Primary site: Chelsea Funded by Breast Cancer Now